---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-017289"
form_type: "8-K"
ticker: "CELC"
cik: "0001603454"
company_name: "Celcuity Inc."
filed_at: "2023-05-15T23:59:59+00:00"
generated_at: "2026-06-15T01:12:00.374307+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Celcuity Q1 2023 net loss $11.9M; Phase 1b gedatolisib shows median PFS 48.6 months

## Summary
- Net loss of $11.9M ($0.55 loss per share) vs $7.9M ($0.53 loss per share) in Q1 2022.
- R&D expenses $11.3M, up from $6.7M, driven by VIKTORIA-1 Phase 3 trial costs.
- Cash and short-term investments $157.5M at March 31, 2023.
- Phase 1b gedatolisib data: median PFS 48.6 months in treatment-naïve HR+/HER2- advanced breast cancer.
- VIKTORIA-1 Phase 3 enrollment on track for primary analysis of PIK3CA WT subgroup in H2 2024.

## SEC filing metadata
- accession: 0001493152-23-017289
- form_type: 8-K
- ticker: CELC
- cik: 0001603454
- company_name: Celcuity Inc.
- filed_at: 2023-05-15T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1603454/000149315223017289/0001493152-23-017289-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1603454/000149315223017289/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-017289
- JSON: https://secwatch.observer/filing/0001493152-23-017289.json
- Plain text: https://secwatch.observer/filing/0001493152-23-017289.txt

## Key facts
- Earnings Releases
  Celcuity Inc. reported first quarter ended March 31, 2023 results: net income Net loss for the first quarter of 2023 was $11.9 million, EPS $0.55 loss per share.
  - Period: first quarter ended March 31, 2023
  - Net income: Net loss for the first quarter of 2023 was $11.9 million
  - EPS: $0.55 loss per share
  - Result: reported results
  source text: Net loss for the first quarter of 2023 was $11.9 million, or $0.55 loss per share, compared to a net loss of $7.9 million, or $0.53 loss per share, for the first quarter of 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1603454/000149315223017289/0001493152-23-017289-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.